Vassiliki Economides - 02 Feb 2023 Form 4 Insider Report for Gritstone bio, Inc.

Role
Executive Vice President & Chief Financial Officer
Signature
/s/ Vassiliki Economides
Issuer symbol
N/A
Transactions as of
02 Feb 2023
Net transactions value
$0
Form type
4
Filing time
06 Feb 2023, 16:28:32 UTC
Previous filing
20 Apr 2022
Next filing
24 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Award $0 +179,058 +779% $0.000000 202,058 02 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") 170,366 of which vest semi-annually over four years and 8,692 of which vest annually over two years from February 1, 2023, in each case, subject to the Reporting Person's continuous service to the Issuer on each such date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2 Includes 179,058 RSUs which are subject to vesting.

Remarks:

Executive Vice President & Chief Financial Officer